Manfred Karobath
Plus aucun poste en cours
Profil
Manfred E.
Karobath served as a Director at QIAGEN NV from 2000 to 2010, and as a Director at Coley Pharmaceutical Group, Inc. from 1999 to 2008.
He also held Director positions at QIAGEN GmbH, Pasteur Mérieux Connaught, Centeon LLC, and Rhone-Poulenc Pharma GmbH.
Additionally, he served as Senior VP & Head-Research & Development at Sandoz AG and as President-Research & Development & Executive VP at Rhone-Poulenc Rorer BV.
Prior to his career in industry, he was a Professor at the University of Vienna.
He holds a doctorate degree from the University of Vienna.
Anciens postes connus de Manfred Karobath
| Sociétés | Poste | Fin |
|---|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Directeur/Membre du Conseil | 07/01/2008 |
| Rhone-Poulenc Pharma GmbH | Directeur/Membre du Conseil | - |
| Rhone-Poulenc Rorer BV | Directeur Technique/Scientifique/R&D | - |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Corporate Officer/Principal | - |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Directeur/Membre du Conseil | - |
Formation de Manfred Karobath
| University of Vienna | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| QIAGEN N.V. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Health Technology |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Commercial Services |
| Pasteur Mérieux Connaught | |
| Centeon LLC | |
| Rhone-Poulenc Rorer BV | |
| Rhone-Poulenc Pharma GmbH |
